
Cell Cycle/Checkpoint
Cell cycle/checkpoint inhibitors are compounds that disrupt the normal progression of the cell cycle, particularly at key regulatory checkpoints. These inhibitors are crucial for studying cell division, understanding cancer cell proliferation, and developing anti-cancer therapies. By targeting specific phases of the cell cycle, these inhibitors can induce cell cycle arrest, leading to apoptosis or senescence in rapidly dividing cells. At CymitQuimica, we offer a diverse range of high-quality cell cycle/checkpoint inhibitors to support your research in cancer biology, cell biology, and drug development.
Subcategories of "Cell Cycle/Checkpoint"
- Aurora Kinase(94 products)
- CDK(500 products)
- Cell Cycle Arrest(4 products)
- Chk(42 products)
- DYRK(48 products)
- Dynamin(23 products)
- Ferroptosis(215 products)
- HSP(169 products)
- Integrin(224 products)
- Kinesin(66 products)
- LIM Kinase(19 products)
- Microtubule Associated(261 products)
- PKC(102 products)
- PLK(28 products)
- ROCK(70 products)
- Rho(2 products)
- Wee1(15 products)
- c-Myc(69 products)
Show 10 more subcategories
Found 3477 products of "Cell Cycle/Checkpoint"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
10-Formyl-5,8-dideazafolic acid
CAS:<p>10-Formyl-5,8-dideazafolic acid is a thymidylate synthase inhibitor.</p>Formula:C22H21N5O7Purity:96.04%Color and Shape:SolidMolecular weight:467.43RSK-IN-1
CAS:<p>RSK-IN-1 (compound 7d) shows anti-tumor activity. RSK-IN-1 is an inhibitor of RSK that inhibits the phosphorylation of YB-1 [1].</p>Formula:C22H17NO2Color and Shape:SolidMolecular weight:327.38CDK9-IN-15
CAS:<p>CDK9-IN-15: potent CDK9 inhibitor, blocks P-TEFb phosphorylation, inhibits transcription, reduces mRNA, induces tumor cell apoptosis.</p>Formula:C16H11N3OSPurity:97.24%Color and Shape:SolidMolecular weight:293.34CTP Synthetase-IN-1
CAS:<p>CTP Synthetase-IN-1 is a cytidine 5'-triphosphate synthetase (CTPS) inhibitor with antitumor activity for the study of arthritis and rheumatoid arthritis.</p>Formula:C20H19F3N6O3S2Purity:98.11% - 99.18%Color and Shape:SolidMolecular weight:512.53SP-471P
CAS:<p>SP-471P inhibits DENV protease; EC50: DENV1-5.9 μM, DENV2-1.4 μM, DENV3-5.1 μM, DENV4-1.7 μM; CC50 >100 μM; lowers viral RNA synthesis.</p>Formula:C33H26BrN5O2Color and Shape:SolidMolecular weight:604.515(S)-HpETE
CAS:<p>15(S)-HpETE is a product of arachidonic acid formed in the 15-lipoxygenase pathway and inhibits angiogenesis.</p>Formula:C20H32O4Color and Shape:SolidMolecular weight:336.47Crisnatol
CAS:<p>Crisnatol (BWA770U) is an oral anticancer DNA intercalator, toxic to breast cancer cells, not skin fibroblasts.</p>Formula:C23H23NO2Color and Shape:SolidMolecular weight:345.43Cdc7-IN-17
CAS:<p>Cdc7-IN-17 is a potent inhibitor of CDC7 with an IC 50 of <10 μM that can be used in cancer research [1].</p>Formula:C13H15N5OSColor and Shape:SolidMolecular weight:289.36CDK2-IN-13
CAS:<p>CDK2-IN-13: Potent CDK2 inhibitor, arrests cell cycle, induces apoptosis, IC50=12 µM, used in cancer research.</p>Formula:C13H12ClN5Color and Shape:SoildMolecular weight:273.72CCG-257081
CAS:<p>CCG-257081 blocks Rho/MRTF/SRF pathway; prevents fibrosis in mice; useful in cancer and fibrosis research.</p>Formula:C24H19ClF3N3O2Purity:99.76% - 99.94%Color and Shape:SolidMolecular weight:473.87GW8510
CAS:<p>GW8510 is a CDK2 and RRM2 inhibitor that affects DNA synthesis and antiproliferation in tumor cells. In mammalian aging models, GW851 prolongs lifespan.</p>Formula:C21H15N5O3S2Purity:99.32%Color and Shape:SolidMolecular weight:449.51CBL 0100 free base
CAS:<p>CBL0100 is an inhibitor of viral transcriptional elongation, blocking both HIV-1 replication and reactivation.</p>Formula:C24H26N2O2Purity:98.18% - 98.86%Color and Shape:SolidMolecular weight:374.483'-Deoxyuridine-5'-triphosphate
CAS:<p>3'-dUTP, a nucleotide analogue, competitively inhibits RNA polymerases I & II, with a Ki of 2.0 µM.</p>Formula:C9H15N2O14P3Color and Shape:SolidMolecular weight:468.14CDK8-IN-7
CAS:<p>CDK8-IN-7 is a potent CDK8 inhibitor with a Kd of 3.5 nM, showing promise for AML research.</p>Formula:C30H40N2Color and Shape:SolidMolecular weight:428.65XVA143
CAS:<p>XVA143, an α/β I-like allosteric antagonist, blocks LFA-1 adhesion and combats P. gingivalis in mice, preventing bone loss.</p>Formula:C25H21Cl2N3O8Color and Shape:SolidMolecular weight:562.36IDD388
CAS:<p>IDD388 is a selective and potent aldose reductase (ALR2) inhibitor with antitumor activity that inhibits the ALR1 receptor.</p>Formula:C16H12BrClFNO4Purity:99.56%Color and Shape:SolidMolecular weight:416.63Laromustine
CAS:<p>Laromustine (VNP40101M) is a sulfonyl hydrolysis alkylation prodrug for cancer treatment with significant anticancer activity, inhibiting thioredoxin reductase.</p>Formula:C6H14ClN3O5S2Purity:≥98%Color and Shape:SolidMolecular weight:307.78HBV-IN-4
CAS:<p>HBV-IN-4, a phthalazinone, inhibits HBV DNA replication orally (IC50: 14 nM), encouraging genome-free capsids with strong anti-HBV effects.</p>Formula:C24H19ClFN5O3Color and Shape:SolidMolecular weight:479.89APC 366
CAS:<p>APC 366: Mast cell tryptase inhibitor, Ki 7.1 μM. Reduces EAR, LAR, BHR in allergic asthma (sheep model).</p>Formula:C22H28N6O4Purity:99.8%Color and Shape:SolidMolecular weight:440.5MLAF50
CAS:<p>MLAF50 is an inhibitor of the REV1 UBM2-Ubiquitin interaction.</p>Formula:C15H12I2O4Color and Shape:SolidMolecular weight:510.06Cdc7-IN-15
CAS:<p>Cdc7-IN-15 (Example 108) is an inhibitor of cdc7 kinase that has potential to be used for cancer research [1].</p>Formula:C12H14N4OSColor and Shape:SolidMolecular weight:262.33CP681301
CAS:<p>CP681301 is a potent CDK5 inhibitor with anti-tumor effects in Drosophila and reduces Glioma stem cells' growth and renewal.</p>Formula:C17H22N4OColor and Shape:SolidMolecular weight:298.38DNA Gyrase-IN-2
CAS:<p>DNA Gyrase-IN-2 inhibits E. coli (IC50: 3.29-10.49 μM) and M. tuberculosis (IC50: 4.41-5.61 μM) COX, has antibacterial properties.</p>Formula:C24H24N8OS2Color and Shape:SolidMolecular weight:504.63CDK7-IN-15
CAS:<p>CDK7-IN-15, a pyrimidine-based potent CDK7 inhibitor, shows promise for various cancers with defective transcription.</p>Formula:C21H24F4N6OSColor and Shape:SolidMolecular weight:484.51DHODH-IN-15
CAS:<p>DHODH-IN-15, a hydroxyfuran analogue of A771726, inhibits rat liver DHODH with an IC50 of 11 μM, and is used for rheumatoid arthritis.</p>Formula:C15H11N3O3Purity:99.8%Color and Shape:SolidMolecular weight:281.27Beaucage reagent
CAS:<p>Beaucage reagent, which is found to be effective in causing DNA cleavage.</p>Formula:C7H4O3S2Purity:98.50%Color and Shape:White To Off-White PowderMolecular weight:200.23WNK1-IN-1
CAS:<p>WNK1-IN-1, a WNK1 inhibitor (IC50: 1.6 μM), also inhibits OSR1 phosphorylation (IC50: 4.3 μM), used in blood pressure and cancer research.</p>Formula:C13H15BrCl2N2O4SPurity:98.09%Color and Shape:SolidMolecular weight:446.14DNA Gyrase-IN-3
CAS:<p>DNA Gyrase-IN-3 inhibits E. coli DNA gyrase B with IC50 5.41-15.64 μM; shows anti-TB and antibacterial properties.</p>Formula:C18H20N6OS2Color and Shape:SolidMolecular weight:400.52Valategrast hydrochloride
CAS:<p>Valategrast hydrochloride (R411), a dual antagonist of integrin α4β1 (VLA-4), is used for the potential treatment of asthma.</p>Formula:C30H33Cl4N3O4Purity:98%Color and Shape:SolidMolecular weight:641.41CH-1504
CAS:<p>CH-1504, dihydrofolate reductase (DHFR) inhibitor, is used potentially for the treatment of rheumatoid arthritis.</p>Formula:C23H23N5O5Color and Shape:SolidMolecular weight:449.46MMV688844
CAS:<p>MMV688844 inhibits M. abscessus DNA cyclooxygenase (IC50: 2μM) and has MIC50 of 12μM on strain bamboo; useful in antimicrobial studies.</p>Formula:C23H25ClN4O2Color and Shape:SolidMolecular weight:424.92CDK7-IN-10
CAS:<p>CDK7-IN-10: CDK7 inhibitor, IC50<100 nM, may hinder cell growth, induce apoptosis. (Patent WO2021016388A1, I-1)</p>Formula:C29H35N7O3Color and Shape:SolidMolecular weight:529.63CDK7-IN-16
CAS:<p>CDK7-IN-16, a potent CDK7 inhibitor (IC50: 1-10 nM), is used in cancer research with transcription defects.</p>Formula:C19H21F3N6O2SColor and Shape:SolidMolecular weight:454.47Y-33075
CAS:<p>Y-33075 (Y-39983 free base) is a ROCK inhibitor that lowers IOP, increases blood flow to ONH, and increases the number of RGCs with regenerating axons.</p>Formula:C16H16N4OPurity:98%Color and Shape:SolidMolecular weight:280.32DHX9-IN-1
CAS:<p>DHX9-IN-1 is a potent ATP-dependent RNA helicase A (DHX9) inhibitor, exhibiting an IC50 of 9.45 nM and demonstrating antitumor activity [1].</p>Formula:C21H21F2N5O3SColor and Shape:SolidMolecular weight:461.49Tripolin A
CAS:<p>Tripolin A is a specific non-ATP competitive inhibitor of Aurora A kinase(Aurora A and Aurora B with IC50 values of 1.5 μM and 7 μM, respectively)</p>Formula:C15H11NO3Purity:98%Color and Shape:SolidMolecular weight:253.255-OHdU
CAS:<p>5-OHdU (5-OHdU) is a major oxidation product of 2'-Deoxycytidine and can be incorporated into DNA in vitro.</p>Formula:C9H12N2O6Purity:99.5%Color and Shape:SolidMolecular weight:244.2DENV-IN-4
CAS:<p>DENV-IN-4: Effective DENV inhibitor (EC50=4.79 μM), low toxicity (CC50>100 μM), and strong selectivity (SI>20.9); suppresses DENV2 and RdRp.</p>Formula:C28H32N4O4SiColor and Shape:SolidMolecular weight:516.66CDK9-IN-14
CAS:<p>CDK9-IN-14: Potent CDK9 inhibitor, IC50=6.92 nM, effective on MV-4-11 cells and in vivo tumors, low toxicity, minimal side effects.</p>Formula:C21H23F2N3O4Color and Shape:SolidMolecular weight:419.42ST7612AA1
CAS:<p>ST7612AA1: potent, oral HDAC inhibitor; reactivates HIV-1 latency; shows antitumor effects; may study malaria.</p>Formula:C20H27N3O4SPurity:99.71%Color and Shape:SolidMolecular weight:405.518-Azido-ADP disodium
CAS:<p>8-Azido-ADP (disodium) is a covalent inhibitor of ADP/ATP exchange in mitochondria, causing irreversible inhibition in light.</p>Formula:C10H13N8NaO10P2Color and Shape:SolidMolecular weight:490.197Triaziquone
CAS:<p>Triaziquone is an alkylating agent that can react with DNA to form intrastrand crosslinks.</p>Formula:C12H13N3O2Color and Shape:SolidMolecular weight:231.25FAK/aurora kinase-IN-1
CAS:<p>FAK/aurora kinase-IN-1, a dual inhibitor of FAK and aurora kinase, has IC50 values of 6.61 nM and 0.91 nM respectively, and demonstrates anticancer effects (WO2018019252A1; compound 11) [1].</p>Formula:C23H24ClN7O3Color and Shape:SolidMolecular weight:481.93tBID
CAS:<p>tBID is a selective homeodomain-interacting protein kinase 2 (HIPK2) inhibitor (IC50 of 0.33 μM)</p>Formula:C11H3Br4N3O2Purity:98%Color and Shape:SolidMolecular weight:528.78P18IN003
CAS:<p>P18IN003 is a selective and effective p18(INK4C) inhibitor that inhibits the activity of p18 protein and can be used to study in vitro expansion of</p>Formula:C17H16N2O3Purity:98.77%Color and Shape:SolidMolecular weight:296.32Cdc7-IN-3
CAS:<p>Cdc7-IN-3 is a potent inhibitor of Cdc7 kinase.</p>Formula:C20H22N4O5Purity:98%Color and Shape:SolidMolecular weight:398.41LCAHA
CAS:<p>LCAHA is a USP2a inhibitor. LCAHA inhibits growth of cyclin D1-dependent cells.</p>Formula:C24H41NO3Color and Shape:SolidMolecular weight:391.59Flurocitabine
CAS:<p>Flurocitabine is a therapeutic agent with antineoplastic activity.</p>Formula:C9H10FN3O4Purity:98%Color and Shape:SolidMolecular weight:243.19DHFR-IN-5
CAS:<p>DHFR-IN-5: potent, oral DHFR inhibitor, Ki 0.54 nM against mutant P. falciparum, anti-malarial.</p>Formula:C18H24N4O4Color and Shape:SolidMolecular weight:360.41FN-1501-propionic acid
CAS:<p>FN-1501-propionic acid, a CDK2/9 ligand, in conjunction with a CRBN ligand, has been utilized in the design of a PROTAC CDK2/9 degrader.</p>Formula:C25H27N9O4Purity:98%Color and Shape:SolidMolecular weight:517.54Zelpolib
CAS:<p>Zelpolib is a specific inhibitor of DNA polymerase δ (Pol δ), inhibiting DNA replication. antiproliferative.</p>Formula:C22H21N3O5S2Purity:98.79%Color and Shape:SolidMolecular weight:471.5510-Methyl-10-deazaaminopterin
CAS:<p>10-Methyl-10-deazaaminopterin is a folate analog that shows antitumor activity.</p>Formula:C21H23N7O5Purity:98%Color and Shape:SolidMolecular weight:453.45N2-Ethylguanosine
CAS:<p>N2-Ethylguanosine is a Nucleoside Derivative - 2-Modified purine nucleoside.</p>Formula:C12H17N5O5Color and Shape:SolidMolecular weight:311.29Y-9738
CAS:<p>Y-9738 is an agent of hypolipidemic.</p>Formula:C15H16ClNO4Purity:98%Color and Shape:SolidMolecular weight:309.74NSC 693868
CAS:<p>CDKs and GSK-3 inhibitor</p>Formula:C9H7N5Purity:98%Color and Shape:SolidMolecular weight:185.19Zaurategrast ethyl ester sulfate
CAS:<p>Zaurategrast ethyl ester sulfate is a α4β1/α4β7 integrin antagonist, and used for the treatment of inflammatory and autoimmune disorders.</p>Formula:C56H60Br2N8O10SPurity:98%Color and Shape:SolidMolecular weight:1197.01HBV-IN-22
CAS:<p>HBV-IN-22 (Compound LC5f) is an HBV DNA replication inhibitor that acts on both wild-type HBV (IC50: 0.71 μM) and drug-resistant HBV (IC50: 0.84 μM).</p>Formula:C26H29N3O2S2Color and Shape:SolidMolecular weight:479.66NSC666715
CAS:<p>NSC666715 is the strand-displacement activity of DNA polymerase inhibitor.</p>Formula:C15H13Cl2N5O2S2Purity:98%Color and Shape:SolidMolecular weight:430.33ROCK2-IN-5
<p>ROCK2-IN-5, a compound blending fasudil, caffeic, and ferulic acids, shows promise for ALS research involving SOD1 mutations.</p>Formula:C23H25N3O5SColor and Shape:SolidMolecular weight:455.53S-(N-PhenethylthiocarbaMoyl)-L-cysteine
CAS:<p>PEITC-Cys: anticarcinogenic, antileukemic, inhibits DNA synthesis in HL60, P450 inhibitor.</p>Formula:C12H16N2O2S2Color and Shape:SolidMolecular weight:284.4Aurora A/PKC-IN-1
CAS:<p>Aurora A/PKC-IN-1 inhibits AurA (IC50: 6.9 nM), PKCα (IC50: 16.9 nM), and hinders breast cancer cell growth and spread.</p>Formula:C16H14N6OSe2Color and Shape:SolidMolecular weight:464.24KIRA-7
CAS:<p>KIRA-7: imidazopyrazine, anti-fibrotic, inhibits IRE1α RNase (IC50: 110 nM) allosterically.</p>Formula:C27H23FN6OColor and Shape:SolidMolecular weight:466.51DHODH-IN-1
CAS:<p>DHODH-IN-1 is a potent dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 25 nM. DHODH-IN-1 is an inhibitor of the pyrimidine biosynthetic pathway.</p>Formula:C21H20F3N3O2Purity:99.76%Color and Shape:SolidMolecular weight:403.4BRD9185
CAS:<p>BRD9185 is an inhibitor of Dihydroorotate dehydrogenase (DHODH) with an EC50 of 16 nM against multidrug-resistant blood-stage parasites in vitro.</p>Formula:C23H21F6N3O2Purity:98%Color and Shape:SolidMolecular weight:485.42Zaurategrast ethyl ester
CAS:<p>Zaurategrast ethyl ester, an α4β1/α4β7 integrin antagonist prodrug of CT7758, treats inflammatory/autoimmune conditions.</p>Formula:C28H29BrN4O3Purity:98%Color and Shape:SolidMolecular weight:549.46DHFR-IN-2
CAS:<p>DHFR-IN-2 (4e) is a potent MtDHFR uncompetitive inhibitor with a 7 μM IC50, promising for TB research.</p>Formula:C14H13NO2Color and Shape:SolidMolecular weight:227.26(E/Z)-BIO-acetoxime
CAS:<p>(E/Z)-BIO-acetoxime: potent GSK-3 α/β inhibitor; IC50: GSK-3α/β 10nM, CDK5/p25 2.4μM, CDK2/A 4.3μM, CDK1/B 63μM.</p>Formula:C18H12BrN3O3Color and Shape:SolidMolecular weight:398.21Capzimin
CAS:<p>Capzimin is a selective inhibitor of proteasome isopeptidase Rpn11.</p>Formula:C30H24N6O2S4Purity:98.31% - 99.32%Color and Shape:SolidMolecular weight:628.818-Deazahomofolic acid
CAS:<p>8-Deazahomofolic acid is a potential thymidylate synthase (TS) inhibitor and other folate related enzymes inhibitor.</p>Formula:C21H22N6O6Purity:98%Color and Shape:SolidMolecular weight:454.44A 65281
CAS:<p>A 65281: antibacterial isothiazoloquinolone, inhibits P4-unknotting, induces DNA breakage via topoisomerase II.</p>Formula:C17H16F2N4O2SPurity:98%Color and Shape:SolidMolecular weight:378.4MFH290
CAS:<p>MFH290 is a selective CDK12/13 inhibitor, covalently bonding with CDK12 Cys-1039, blocks Pol II CTD phosphorylation, and enhances olaparib's efficacy.</p>Formula:C26H31N5O3S2Color and Shape:SolidMolecular weight:525.69RHI002-Me
CAS:<p>RHI002-Me is a methylated derivative of RHI002, a selective inhibitor of human RNaseH2.</p>Formula:C18H19N3O2S2Purity:98%Color and Shape:SolidMolecular weight:373.49Direct Black 38 free acid
CAS:<p>Ferristatin II (Direct Black 38 free acid) is a polysulphonated dye and promotes the degradation of transferrin receptor-1 in vitro and in vivo.</p>Formula:C34H27N9O7S2Purity:98%Color and Shape:SolidMolecular weight:737.77ROCK-IN-D2
CAS:<p>ROCK-IN-D2 is an effective and selective inhibitor of ROCK.</p>Formula:C22H28N6OPurity:98%Color and Shape:SolidMolecular weight:392.5Atuveciclib S-Enantiomer
CAS:<p>Atuveciclib S-Enantiomer is a (S)-form of BAY-1143572; a potent, selective CDK9 inhibitor with an IC50 of 16 nM.</p>Formula:C18H18FN5O2SPurity:98%Color and Shape:SolidMolecular weight:387.43RET-IN-19
CAS:<p>RET-IN-19, a potent RET inhibitor, anticancer: IC50 6.8 nM (RET-wt), 13.51 nM (RET V804M); for NSCLC research.</p>Formula:C28H28N6O4SColor and Shape:SolidMolecular weight:544.62(R)-Filanesib
CAS:<p>(R)-Filanesib is the R-enantiomer of ARRY-520. (R)-Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor (IC50: 6 nM).</p>Formula:C20H22F2N4O2SColor and Shape:SolidMolecular weight:420.48Apricitabine
CAS:<p>Apricitabine (SPD754) is a highly selective and orally active HIV-1 reverse transcriptase inhibitor (Ki=0.08 μM), the (-) enantiomer of 2′-deoxy-3′-oxy-4′-</p>Formula:C8H11N3O3SPurity:99.45%Color and Shape:SolidMolecular weight:229.26PD 130883
CAS:<p>PD 130883 is a potent lipophilic quinazoline antifolate.</p>Formula:C18H15N5O3Purity:98%Color and Shape:SolidMolecular weight:349.34RP-106
CAS:<p>RP-106 is an ATP-competitive inhibitor of CDK5/p25, CDK1/cyclin B, and GSK-3.</p>Formula:C17H19N3OPurity:98%Color and Shape:SolidMolecular weight:281.35A 65282
CAS:<p>A 65282: antibacterial isothiazoloquinolone, inhibits P4-unknotting, causes DNA breaks via topoisomerase II.</p>Formula:C17H16F2N4O2SPurity:98%Color and Shape:SolidMolecular weight:378.4CDK8-IN-10
CAS:<p>CDK8-IN-10 is a selective and potent inhibitor of cell cycle protein-dependent kinase (CDK8) (IC50: 8.25 nM) that can be used to study cancer.</p>Formula:C25H15ClF3N5O3Color and Shape:SolidMolecular weight:525.87CDK4/6-IN-8
CAS:<p>CDK4/6-IN-8 (Compound 7p) is a selective inhibitor of CDK4 (IC50=5.01 nM) and CDK6 (IC50=3.97 nM).</p>Formula:C18H18N6O5Color and Shape:SolidMolecular weight:398.37IMB-10
CAS:<p>IMB-10 is an alphaMbeta2 integrin modulator, inhibiting leukocyte migration and recruitment in vitro and in vivo.</p>Formula:C19H15NOS2Color and Shape:SolidMolecular weight:337.46CRT5
CAS:<p>CRT5, a selective PKD inhibitor, blocks VEGF effects on histone deacetylase 5, CREB, HSP27, and endothelial functions. IC50s: 1-2 nM for PKD1-3.</p>Formula:C28H30N4O2Color and Shape:SolidMolecular weight:454.56AnnH31
CAS:<p>AnnH31 is a potent Dyrk1A inhibitor with an IC50 value of 81 nM.AnnH31 inhibits MAO-A with an IC50 of 3.2 μM.AnnH31 can be used as a probe to confirm the</p>Formula:C15H13N3OPurity:99.88%Color and Shape:SolidMolecular weight:251.28hDHODH-IN-4
CAS:<p>hDHODH-IN-4, a potent DHODH inhibitor, has a pIC50 of 7.8 and blocks measles virus replication with a pMIC50 of 8.8.</p>Formula:C21H24N4O2Purity:99.87%Color and Shape:SolidMolecular weight:364.44SC-203885
CAS:<p>SC-203885 is a checkpoint kinase 2 inhibitor.</p>Formula:C15H13N5O2Purity:98%Color and Shape:SolidMolecular weight:295.3DHODH-IN-24
CAS:<p>DHODH-IN-24 (compound 16) serves as a powerful inhibitor of human dihydroorotate dehydrogenase (DHODH), exhibiting an IC50 value of 91 nM [1].</p>Formula:C26H26N4Color and Shape:SolidMolecular weight:394.51Kira8 Hydrochloride
CAS:<p>Kira8 Hydrochloride is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity with an IC50 of 5.9 nM.</p>Formula:C31H30Cl2N6O3SPurity:98%Color and Shape:SolidMolecular weight:637.58Clociguanil
CAS:<p>Clociguanil has antimalarial activity.</p>Formula:C12H15Cl2N5OColor and Shape:SolidMolecular weight:316.19CDK4/6-IN-12
CAS:<p>CDK4/6-IN-12 inhibits CDK4/6 with IC50s of 592.3 nM & 3090 nM, useful in cancer research.</p>Formula:C12H10N6Color and Shape:SolidMolecular weight:238.25Tenofovir exalidex
CAS:<p>Tenofovir exalidex (CMX 157) is a lipid-conjugated acyclic nucleotide analog of Tenofovir, demonstrating efficacy against wild-type and antiretroviral-resistant</p>Formula:C28H52N5O5PPurity:99.83%Color and Shape:SolidMolecular weight:569.72BPIC
CAS:<p>BPIC is an agent of anti-tumor that acts by inhibiting inflammation and scavenging free radicals.</p>Formula:C27H20N2O5Color and Shape:SolidMolecular weight:452.46Levofloxacin sodium
CAS:<p>Levofloxacin sodium: synthetic antibacterial, stops DNA replication by inhibiting bacterial DNA gyrase.</p>Formula:C18H20FN3NaO4Purity:98%Color and Shape:SolidMolecular weight:384.363FRα-IN-1
CAS:<p>FRα-IN-1 (Compound 4) is a tumour targeting agent. FRα-IN-1 exhibits selective anti-cancer effects on FRα and FRβ expressing cells.</p>Formula:C21H24N6O6Color and Shape:SolidMolecular weight:456.45CLK1-IN-2
<p>CLK1-IN-2: Metabolically stable, Clk1-selective inhibitor; IC50=1.7nM; useful in tumor, Duchenne MD, HIV-1, influenza research.</p>Formula:C16H12Cl2N2O2SColor and Shape:SolidMolecular weight:367.25TDRL-X80
CAS:<p>TDRL-X80 inhibits XPA DNA binding; effective on single, double, and cisplatin-damaged DNA; IC50: 18-29 μM (FP), 21-39 μM (ELISA).</p>Formula:C23H15ClN2O6Color and Shape:SolidMolecular weight:450.83Metioprim
CAS:<p>Metioprim is a competitive bacterial dihydrofolate reductases inhibitor.</p>Formula:C14H18N4O2SPurity:98%Color and Shape:SolidMolecular weight:306.38XL-188
CAS:<p>XL-188: Potent, selective USP7 inhibitor, IC50 = 193 nM (domain), 90 nM (full). Boosts p53, p21; degrades HDM2. Unique among DUB inhibitors.</p>Formula:C32H42N6O4Color and Shape:SolidMolecular weight:574.71Nucleoside-Analog-1
CAS:<p>Nucleoside-Analog-1 is a 4′-Azidocytidine analogue, used to against Hepatitis C virus replication.</p>Formula:C9H9N5O5Purity:98%Color and Shape:SolidMolecular weight:267.2L-Fd4A
CAS:<p>L-Fd4A (compound 36) is an adenine derivative with anti-HIV (EC50=1.5μM) and anti-HBV (EC50=1.7μM) effects, low cytotoxicity.</p>Formula:C10H10FN5O2Color and Shape:SolidMolecular weight:251.22BPKDi
CAS:<p>BPKDi is a potent and selective inhibitor of PKD (protein kinase D).</p>Formula:C21H28N6OPurity:98%Color and Shape:SolidMolecular weight:380.49Aloisine A
CAS:<p>Aloisine A, a CDK/GSK-3 inhibitor with IC50: Cdk1/B-150nM, Cdk2/A-120nM, Cdk2/E-400nM, Cdk5/25-200nM, Cdk5/35-160nM, GSK-3α-500nM, GSK-3β-650nM, JNK-3-10μM.</p>Formula:C16H17N3OPurity:98%Color and Shape:SolidMolecular weight:267.33CCT068127
CAS:<p>CCT068127 is a potent CDK2 and CDK9 inhibitor.</p>Formula:C19H27N7OColor and Shape:SolidMolecular weight:369.46hDHODH-IN-5
CAS:<p>hDHODH-IN-5 is an inhibitor of human dihydroorotate dehydrogenase (hDHODH, IC50 = 0.91 μM).</p>Formula:C21H21F3N2O2Purity:99.55%Color and Shape:SolidMolecular weight:390.4DHODH-IN-13
CAS:<p>DHODH-IN-13 is an inhibitor of DHODH with IC50 of 4.3 μM for rat liver. DHODH-IN-13 can be used in studies about rheumatoid arthritis.</p>Formula:C10H6F3N3O3Purity:99.66%Color and Shape:SolidMolecular weight:273.17(S)-CR8
CAS:<p>(S)-CR8 is an effective second-generation cyclin-dependent kinase inhibitor.</p>Formula:C24H29N7OColor and Shape:SolidMolecular weight:431.53hDHODH-IN-3
CAS:<p>hDHODH-IN-3 is an inhibitor of human dihydroorotate dehydrogenase with a pMIC50 value of 8.6. hDHODH-IN-3 can inhibit measles virus replication.</p>Formula:C18H19BrN4O2Purity:99.871%Color and Shape:SolidMolecular weight:403.27BMVC
CAS:<p>BMVC is a potent G-quadruplex (G4) stabilizer and a selective telomerase inhibitor (IC50: ~0.2 μM) with anticancer activities.</p>Formula:C28H25I2N3Color and Shape:SolidMolecular weight:657.33TP1287
CAS:<p>TP-1287 is an oral phosphate prodrug of the CDK9 inhibitor, alvocidib.</p>Formula:C21H21ClNO8PColor and Shape:SolidMolecular weight:481.82L-Cytidine
CAS:<p>L-Cytidine, pyrimidine nucleoside in RNA, regulates glial glutamate, brain lipids, catecholamines, and mitochondria.</p>Formula:C9H13N3O5Color and Shape:SolidMolecular weight:243.22CDK2-IN-11
CAS:<p>CDK2-IN-11 inhibits CDK2 (IC50: 6.4 μM) and targets hCA II, IX, XII (Ki: 23.4-56.3 nM); suited for cancer research.</p>Formula:C18H14ClN7O2SColor and Shape:SolidMolecular weight:427.87Braco-19 trihydrochloride
CAS:<p>BRACO19 3HCl inhibits telomerase, blocking its capping function, and prevents HAdV viral replication.</p>Formula:C35H46Cl3N7O2Purity:98.74%Color and Shape:SolidMolecular weight:703.14(S)-LY3177833 hydrate
CAS:<p>(S)-LY3177833 ((S)-Example 2) hydrate, an orally active CDC7 kinase inhibitor, exhibits extensive in vitro anticancer efficacy.</p>Formula:C16H14FN5O2Color and Shape:SolidMolecular weight:327.31Bofumustine
CAS:<p>Bofumustine is a chloroethyl nitrosourea with anti tumor properties.</p>Formula:C18H21ClN4O9Color and Shape:SolidMolecular weight:472.83Levoleucovorin disodium
CAS:<p>Levoleucovorin disodium is the sodium salt of the enantiomerically active form of Folinic Acid.</p>Formula:C20H21N7Na2O7Purity:98%Color and Shape:SolidMolecular weight:517.41Nitracrine
CAS:<p>Nitracrine: a 1-nitroacridine, hypoxia-selective, anti-tumor agent; inhibits RNA synthesis, binds DNA reversibly and forms covalent adducts.</p>Formula:C18H20N4O2Purity:98%Color and Shape:SolidMolecular weight:324.38ProTAME
CAS:<p>ProTAME inhibits APC/CFzr & APC/CCdc20, enhances cell death with doxorubicin/etoposide in primary/MM cells, especially after TOPIIα upregulation.</p>Formula:C34H38N4O12SPurity:98%Color and Shape:SolidMolecular weight:726.75Eg5 Inhibitor V, trans-24
CAS:<p>Eg5 Inhibitor V, trans-24 is a specific and potent Eg5 inhibitor that can be used in cancer research with an IC50 value of 0.65 uM.</p>Formula:C26H21N3O3Purity:99.75%Color and Shape:SolidMolecular weight:423.46DDD100097
CAS:<p>DDD100097 is a N-myristoyltransferase inhibitor with potential inhibitory effects on Trypanosoma brucei, which can be used to study neurological disorders.</p>Formula:C22H30Cl2F2N4O2SPurity:98.89%Color and Shape:SolidMolecular weight:523.47LY 222306
CAS:<p>LY 222306 is a glycinamide ribonucleotide formyltransferase (GARFT) inhibitor with a Ki of 0.77 nM.</p>Formula:C19H23N5O7Purity:98%Color and Shape:SolidMolecular weight:433.42Ipivivint
CAS:<p>Ipivivint: orally active, potent CLK inhibitor; hinders CLK1, CLK2, & CLK3; curbs Wnt signaling & SRSF phosphorylation for cancer research.</p>Formula:C26H21FN8Color and Shape:SolidMolecular weight:464.5DHODH-IN-8
CAS:<p>DHODH-IN-8 is a DHODH inhibitor with antimalarial properties, IC50: 0.13 μM (human), 47.4 μM (P. falciparum); Ki: 0.016 μM (human), 5.6 μM (P. falciparum).</p>Formula:C17H13ClN2O2Purity:99.78%Color and Shape:SolidMolecular weight:312.75AS-136A
CAS:<p>AS-136A is an orally active MV RdRp inhibitor with antiviral activity that inhibits measles virus and blocks viral RNA synthesis.</p>Formula:C17H19F3N4O3SPurity:98.52%Color and Shape:SolidMolecular weight:416.42Synucleozid
CAS:<p>Synucleozid is a potent the SNCA mRNA inhibitor that encodes α-synuclein protein (IC50=1.5 μM), has the potential for the investigation of Parkinson’s disease.</p>Formula:C22H20N6Purity:98%Color and Shape:SolidMolecular weight:368.43OM-137
CAS:<p>OM137 inhibits Aurora kinases, impedes cell growth at high doses, and enhances low-dose paclitaxel effects.</p>Formula:C13H14N4O3SColor and Shape:SolidMolecular weight:306.34VRX-0466617
CAS:<p>VRX-0466617 is a novel selective Chk2 inhibitor.</p>Formula:C19H20BrN5O2SColor and Shape:SolidMolecular weight:462.36CDK2-IN-12
CAS:<p>CDK2-IN-12 (10b), potent CDK2 inhibitor, IC50: 11.6 μM; inhibits hCA I/II/IX/XII, KI: 3534/638.4/44.3/48.8 nM; anti-cancer properties.</p>Formula:C20H17N9O2SColor and Shape:SolidMolecular weight:447.47CDK8-IN-6
CAS:<p>CDK8-IN-6 (compound 9) is a potent inhibitor of cyclin-dependent kinase 8 (CDK8) (Kd: 13 nM), CDK8-IN-6 showed potential research value in AML cancers.</p>Formula:C26H37ClN2Color and Shape:SolidMolecular weight:413.04KH-CB19
CAS:<p>KH-CB19 is an effective and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4).</p>Formula:C15H13Cl2N3O2Color and Shape:SolidMolecular weight:338.19Dyrk1A-IN-3
CAS:<p>Dyrk1A-IN-3 is a selective DYRK1A inhibitor with an IC50 of 76 nM, useful for neurodegenerative disease research.</p>Formula:C18H16N6Color and Shape:SolidMolecular weight:316.363,6-DMAD dihydrochloride
CAS:<p>3,6-DMAD dihydrochloride: Potent IRE1α-XBP1s inhibitor, affects IL-6 secretion and RNase activity, used in cancer research.</p>Formula:C22H33Cl2N5Color and Shape:SolidMolecular weight:438.44CDK5 inhibitor 20-223
CAS:<p>CDK5 inhibitor 20-223 is a potent CDK2/CDK5 inhibitor,anti-Colorectal Cancer (CRC), inhibiting cell migration and inducing cell cycle arrest.</p>Formula:C19H19N3OColor and Shape:SolidMolecular weight:305.37PF-4950834
CAS:<p>PF-4950834, a ATP-competitive, selective Rho kinase inhibitor, provides therapeutic benefits in chronic inflammatory diseases.</p>Formula:C21H19N3O2Purity:98%Color and Shape:SolidMolecular weight:345.39PV-1115
CAS:<p>PV-1115 is an effective and highly selective inhibitor of the Chk2.</p>Formula:C20H19N7O3Purity:98%Color and Shape:SolidMolecular weight:405.412-Fluoroadenine
CAS:<p>2-Fluoroadenine (NSC-27364) has toxicity in nonproliferating and proliferating tumor cells. 2-Fluoroadenine can be used for anticancer studies.</p>Formula:C5H4FN5Purity:98.84% - 99.62%Color and Shape:White To Light Yellow Crystal PowderMolecular weight:153.12HIV-1 inhibitor-43
CAS:<p>HIV-1 Inhibitor-43 suppresses HIV-1, with EC50: 21.3 nM (Y188L), 6.2 nM (K103N-Y181C), <0.7 nM (K103N/Y181C), and lowers HIV RNA/p24 protein.</p>Formula:C24H21ClN2O4SColor and Shape:SolidMolecular weight:468.95Litronesib Racemate
CAS:<p>Litronesib is a selective, allosteric inhibitor of kinesin Eg5.Litronesib (Racemate) is the racemate of litronesib.</p>Formula:C23H37N5O4S2Color and Shape:SolidMolecular weight:511.7GP29
CAS:<p>GP29 is a Type II kinase inhibitor of the IRE1α endoribonuclease that acts by targeting the ATP-binding pocket of IRE1α.</p>Formula:C33H28F3N5O3Purity:98%Color and Shape:SolidMolecular weight:599.6BMVC2
CAS:<p>BMVC2 (o-BMVC), a carbazole derivative of BMVC, is a G-quadruplex (G4) stabilizer.</p>Formula:C28H25I2N3Color and Shape:SolidMolecular weight:657.33BMH-22
CAS:<p>BMH-22 is an RNA polymerase I inhibitor that acts by causing nucleolar stress and showing potent anticancer activity across many tumor types.</p>Formula:C16H17N3Color and Shape:SolidMolecular weight:251.33MSC-1186
CAS:<p>MSC-1186 selectively inhibits SRPKs—IC50: 2.7nM (SRPK1), 81nM (SRPK2), 0.6nM (SRPK3)—for cancer research.</p>Formula:C19H17ClFN7O2SColor and Shape:SolidMolecular weight:461.9(Rac)-Managlinat dialanetil
CAS:<p>Managlinat dialanetil, an orally available and potent inhibitor of fructose 1,6-bisphosphatase (FBPase) used in research 2 type diabetes.</p>Formula:C21H33N4O6PSPurity:98.52%Color and Shape:SolidMolecular weight:500.55Carbonic anhydrase inhibitor 14
CAS:<p>CA inhibitor 14 blocks hCA I/II/IX/XII (K i of 1203/99.7/9.4/27.7 nM) and CDK2 (IC50: 20.3 μM), showing antitumor effects.</p>Formula:C18H17N7O2SColor and Shape:SolidMolecular weight:395.44DHODH-IN-12
CAS:<p>DHODH-IN-12 is a leflunomide derivative and a weak dihydrorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.07.</p>Formula:C10H9N3O2Purity:99.53%Color and Shape:SolidMolecular weight:203.2Bis-Pro-5FU
CAS:<p>Bis-Pro-5FU enhances oral uptake and safety of 5-FU, an anti-cancer drug for colorectal and pancreatic tumors.</p>Formula:C10H7FN2O2Color and Shape:SolidMolecular weight:206.17DHODH-IN-20
CAS:<p>Dhodh-in-20 (Compound 133), a potent DHODH inhibitor, may help study acute myeloid leukemia and inhibit tumor growth.</p>Formula:C24H25F4N3O3Color and Shape:SolidMolecular weight:479.47CGP 53353
CAS:<p>CGP 53353 (DAPH-7) is a PKC inhibitor with inhibitory effects on PKCβII and PKCβI and can be used to study atherosclerosis.</p>Formula:C20H13F2N3O2Purity:98.11%Color and Shape:SolidMolecular weight:365.33Fozivudine tidoxil
CAS:<p>Fozivudine tidoxil, a reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.</p>Formula:C35H64N5O8PSColor and Shape:SolidMolecular weight:745.95JFN05510
CAS:<p>Compound: 3'-O-tert-BDMS-5'-O-DMT-N2-IBG 2'-CE phosphoramidite; has anticancer properties and activates enzymes.</p>Formula:C50H68N7O9PSiColor and Shape:SolidMolecular weight:970.18Aditoprime
CAS:<p>Aditoprime inhibits bacterial growth by blocking DHFR, effective against L.casei and E.coli with IC50 of 520/47 nM.</p>Formula:C15H21N5O2Color and Shape:SolidMolecular weight:303.36PKC-9
CAS:<p>PKC-9 is a PKC-zeta inhibitor 9.</p>Formula:C25H25N7Color and Shape:SolidMolecular weight:423.512-Keto-D-galactose
CAS:<p>2-Keto-D-galactose inhibits DNA synthesis and inhibits the proliferation of in vitro grown Ehrlich ascites tumor cells.</p>Formula:C6H10O6Purity:98%Color and Shape:SolidMolecular weight:178.14CAP-53194
CAS:<p>CAP-53194 is a selective Plk1 inhibitor.</p>Formula:C21H14N6O5Purity:98%Color and Shape:SolidMolecular weight:430.37GSK-3008348
CAS:<p>GSK-3008348 is an antagonist of integrin alpha(v)beta6.</p>Formula:C29H37N5O2Purity:99.547%Color and Shape:SolidMolecular weight:487.64Mivobulin Isethionate
CAS:<p>Mivobulin, a tubulin inhibitor (CI-980), may treat glioma, melanoma, prostate, and ovarian cancer, targeting colchicine-binding site.</p>Formula:C19H25N5O6SPurity:98%Color and Shape:SolidMolecular weight:451.5BAY-707
CAS:<p>BAY-707: tolerable in mice, no anticancer efficacy; potent, selective MTH1 inhibitor, IC50 = 2.3 nM; good PK profile.</p>Formula:C15H20N4O2Purity:98%Color and Shape:SolidMolecular weight:288.34Picoplatin
CAS:<p>Picoplatin, an anti-cancer agent overcoming platinum resistance, alkylates DNA to block replication, transcription, and induce apoptosis.</p>Formula:C6H10Cl2N2PtPurity:98%Color and Shape:SolidMolecular weight:376.14HHL-6
CAS:<p>HHL-6 is a c-Fos and BDNF protein expression modulator.</p>Formula:C19H26N2O3Color and Shape:SolidMolecular weight:330.42Fosteabine
CAS:<p>Fosteabine is an oral and prodrug analog of cytarabine. It is resistant to deoxycytidine deaminase.</p>Formula:C27H50N3O8PPurity:98%Color and Shape:SolidMolecular weight:575.67Metralindole HCl
CAS:<p>Metralindole is a reversible monoamine oxidase A (RIMA) inhibitor, it was investigated as a potential antidepressant.</p>Formula:C15H18ClN3OPurity:98%Color and Shape:SolidMolecular weight:291.78HR22C16
CAS:<p>HR22C16 is an effective, selective, and cell-permeable mitotic kinesin Eg5 inhibitor.</p>Formula:C23H23N3O3Color and Shape:SolidMolecular weight:389.45HIPP
CAS:<p>HIPP is a highly selective inhibitor of antineoplastic CtBP.</p>Formula:C9H9NO3Color and Shape:SolidMolecular weight:179.17NPD9948
CAS:<p>NPD9948 is a competitive inhibitor of MTH1.</p>Formula:C13H14N6Color and Shape:SolidMolecular weight:254.29LDN-209929
CAS:<p>LDN-209929 2HCl is a potent and selective inhibitor of haspin kinase.</p>Formula:C17H17ClN2OSColor and Shape:SolidMolecular weight:332.85DYRKi
CAS:<p>DYRKi is a nontoxic, DYRK1-selective inhibitor.</p>Formula:C20H13F3N4O2SColor and Shape:SolidMolecular weight:430.4BIPM
CAS:<p>BIPM inhibits ROCK2, alters SH-SY5Y cell migration, actin fibers, neurite length, and reduces cofilin phosphorylation.</p>Formula:C23H22N2O3Color and Shape:SolidMolecular weight:374.43Cdc7-IN-14
CAS:<p>Cdc7-IN-14 (compound 82) is a potent CDC7 inhibitor with an IC50 < 1 nM, promising for cancer research.</p>Formula:C18H20N4O2SColor and Shape:SolidMolecular weight:356.44Rho-Kinase-IN-2
CAS:<p>Rho-Kinase-IN-2, an oral ROCK inhibitor (IC50=3nM), penetrates the CNS; potential in Huntington's research.</p>Formula:C20H25FN4O2Color and Shape:SolidMolecular weight:372.44L-Guanosine
CAS:<p>L-Guanosine is the L-configuration of Guanosine. Guanosine is a purine nucleoside that has anti-herpesvirus activity [1] [2].</p>Formula:C10H13N5O5Color and Shape:SolidMolecular weight:283.24REV7/REV3L-IN-1
CAS:<p>REV7/REV3L-IN-1 is a inhibitor of REV7/REV3L interaction(IC50 of 78 μM),</p>Formula:C19H21N3O3SPurity:98%Color and Shape:SolidMolecular weight:371.45NSC47924
CAS:<p>NSC47924 is a laminin receptor (LR) inhibitor.</p>Formula:C18H17NO2Purity:98%Color and Shape:SolidMolecular weight:279.33AB-182
CAS:<p>AB-182 is an aziridine derivative with antitumor activity.</p>Formula:C11H22N3O4PColor and Shape:SolidMolecular weight:291.28Ro 43-5054
CAS:<p>Ro 43-5054 is a small molecular, noncyclic peptidomimetic inhibitor.</p>Formula:C24H27N5O7Purity:98%Color and Shape:SolidMolecular weight:497.5ROCK-IN-D1
CAS:<p>ROCK-IN-D1 is an effective and selective inhibitor of ROCK.</p>Formula:C22H27N5O2SPurity:98%Color and Shape:SolidMolecular weight:425.55UIAA-II-232
CAS:<p>UIAA-II-232 (compound 19b) is a potent inhibitor of DNA gyrase catalytic (IC 50= 3.5 μM).</p>Formula:C20H24FN5O3Color and Shape:SolidMolecular weight:401.43Protein kinase D inhibitor 1
CAS:<p>Protein kinase D inhibitor 1 (17m) is a potent pan-PKD suppressant with IC50 of 17-35 nM, targeting cortactin phosphorylation.</p>Formula:C19H21N7Color and Shape:SolidMolecular weight:347.42SNX2-1-108
CAS:<p>SNX2-1-108 is a selective CDK8 and CDK19 inhibitor.</p>Formula:C21H16N4Purity:98%Color and Shape:SolidMolecular weight:324.38LIMK-IN-14
CAS:<p>LIMK-IN-14 is an effective and selective inhibitor of LIMK.</p>Formula:C22H27N7O3Purity:98%Color and Shape:SolidMolecular weight:437.49Denopterin
CAS:<p>Denopterin is an antineoplastic agent.</p>Formula:C21H23N7O6Purity:98%Color and Shape:SolidMolecular weight:469.45RK-9123016
CAS:<p>RK-9123016 is a SIRT2 inhibitor.</p>Formula:C16H18N6O3SPurity:99.65%Color and Shape:SolidMolecular weight:374.421-Acetyl-3-o-toluyl-5-fluorouracil
CAS:<p>1-Acetyl-3-o-toluyl-5-fluorouracil is a potent antineoplastic agent.</p>Formula:C14H11FN2O4Purity:98%Color and Shape:SolidMolecular weight:290.25MK-0668
CAS:<p>MK-0668 is a very potent and orally active very late antigen-4 antagonist.</p>Formula:C31H30Cl2N6O6SColor and Shape:SolidMolecular weight:685.58BI-831266
CAS:<p>BI-831266 is a potent and selective Aurora kinase B inhibitor.</p>Formula:C27H38ClN7O2Color and Shape:SolidMolecular weight:528.09Aurora Kinases-IN-2
CAS:<p>Aurora Kinases-IN-2 (12Aj) hinders Aurora A/B kinases (IC50: 90/152 nM), used in cancer studies.</p>Formula:C22H18ClN5O3Color and Shape:SolidMolecular weight:435.86Rabacfosadine succinate
CAS:<p>Rabacfosadine succinate is the acyclic nucleoside phosphonate PMEG double prodrug.</p>Formula:C25H41N8O10PPurity:98%Color and Shape:SolidMolecular weight:644.623Thiamiprine
CAS:<p>Thiamiprine is an agent with the activity of antineoplastic.</p>Formula:C9H8N8O2SColor and Shape:SolidMolecular weight:292.28Meturedepa
CAS:<p>Meturedepa is an antineoplastic agent.</p>Formula:C11H22N3O3PPurity:98%Color and Shape:SolidMolecular weight:275.28BMH-23
CAS:<p>BMH-23 is an RNA polymerase I inhibitor that acts by causing nucleolar stress and showing potent anticancer activity across many tumor types.</p>Formula:C15H15N3Purity:98%Color and Shape:SolidMolecular weight:237.3(R)-DRF053 dihydrochloride
CAS:<p>cdk/CK1 inhibitor,potent and ATP-competitive</p>Formula:C23H29Cl2N7OPurity:98%Color and Shape:SolidMolecular weight:490.43BzDANP
CAS:<p>BzDANP is a modulator of pre-miR-29a maturation by Dicer.</p>Formula:C18H24N6Color and Shape:SolidMolecular weight:324.42L 703014
CAS:<p>L 703014 is an antagonist of the fibrinogen receptor.</p>Formula:C24H34N4O4Purity:98%Color and Shape:SolidMolecular weight:442.55SEC inhibitor KL-2
CAS:<p>KL-2: potent SEC inhibitor, selectively disrupts AFF4-CCNT1, dose-dependent, Ki: 1.50 μM.</p>Formula:C17H13ClFNO3Purity:99.86%Color and Shape:SolidMolecular weight:333.74Aurora kinase inhibitor-9
CAS:<p>Aurora kinase inhibitor-9 (9d) targets AURKA/B with IC50: 0.093 μM for A and 0.09 μM for B, with wide anti-proliferative effects.</p>Formula:C19H17Cl2N3O4SColor and Shape:SolidMolecular weight:454.33PV-1019
CAS:<p>PV-1019 (NSC 744039), a potent Chk2 inhibitor, has an IC50 of 24 nM and blocks Chk2 autophosphorylation and IR-induced apoptosis.</p>Formula:C18H17N7O3Color and Shape:SolidMolecular weight:379.37LSN 3213128
CAS:<p>LSN 3213128: a potent oral antifolate targeting AICARFT with IC50s of 16 nM (enzyme) and 19 nM (cells), offers anti-tumor effects.</p>Formula:C17H16FN3O4S2Color and Shape:SolidMolecular weight:409.45JTK-101
CAS:<p>JTK-101 is a potent and selective Tat-dependent HIV-1 replication inhibitor.</p>Formula:C25H23N3O3Color and Shape:SolidMolecular weight:413.47Scaff10-8
CAS:<p>Scaff10-8 blocks AKAP-Lbc-RhoA, aiding aquaporin-2 movement in kidney cells.</p>Formula:C22H18O6Purity:98%Color and Shape:SolidMolecular weight:378.37LDN-209929 dihydrochloride
CAS:<p>LDN-209929 dihydrochloride: potent haspin kinase inhibitor, 55 nM IC50, 180x more selective than DYRK2.</p>Formula:C17H19Cl3N2OSColor and Shape:SolidMolecular weight:405.77
